News

The Purdue Undergraduate Research Conference is the largest showcase of undergraduate research. This judged event highlights the scholarly work and creative endeavors undergraduate students have been ...
For the poster symposia, you will indicate which ... or watch a live session for the virtual conference presentations. For questions before an in-person event, please contact [email protected].
SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to ...
Where bold ideas could meet big opportunities, students have access to innovation and entrepreneurship in Purdue Innovates' annual startup and tech expo.
Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP ...
Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE ...
"We are thrilled that our research involving our selective degrader programs for SMARCA2, CDK2 and IKZF2 will be showcased prominently at AACR 2025, including during two oral presentations ...
United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at the International Society for Heart and Lung ...
today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...
Do you find giving presentations stressful ... about marketing in the presentation I might say ‘we've found that red posters are not only more likely to be seen by customers.
today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...